ArticleJournal for immunotherapy of cancer2026

Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy.

Samya Aouad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.